Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice is a research paper published in Neurotherapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIMH NIH HHS
Grant: P30 MH062261
NIMH NIH HHS
Grant: R01 MH115860
NINDS NIH HHS
Grant: R01 NS034239
NINDS NIH HHS
Grant: R01 NS097195
NIAID NIH HHS
Grant: R01 AI145542
NIAID NIH HHS
Grant: R56 AI138613
NINDS NIH HHS
Grant: T32 NS105594
NIDA NIH HHS
Grant: P01 DA028555
NIMH NIH HHS
Grant: R01 MH121402
NIA NIH HHS
Grant: R01 AG043540
NIGMS NIH HHS
Grant: P20 GM103427
National Institutes of Health
Grant: 5P30MH062261-17
Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center
National Institutes of Health
Grant: 1P01MH064570-01
Targeted Neuroprotection for HIV-1 Associated Dementia
National Institutes of Health
Grant: 1P01NS043985-01A1
Cells and Tissue Core
National Institutes of Health
Grant: 3P20GM103427-23S2
Nebraska Research Network in Functional Genomics
National Institutes of Health
Grant: 3R01NS036126-01S2
HIV-1, MONOCYTES AND THE BLOOD/BRAIN BARRIER
National Institutes of Health
Grant: 5P01DA028555-07
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence
National Institutes of Health
Grant: 1R01AG043540-01A1
SMART HAND
National Institutes of Health
Grant: 5P01NS031492-05
MOLECULAR MECHANISM OF HIV-1-MEDIATED ENCEPHALOPATHY
National Institutes of Health
Grant: 5R01NS034239-26
Neuroprotective Immunity and HIV Dementia
FWCI
1.54
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
Additional file 1 of An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
Additional file 2 of An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
Additional file 2 of An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
Additional file 1 of Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
Additional file 2 of Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
Additional file 2 of Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
Additional file 1 of Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice